Siro has over fifteen years of scientific and international management experience across the whole research, development, commercialization, and investment process in new technologies. Siro is Co-Founder and CEO of Molecular Warehouse an mHealth molecular diagnostics platform. Our vision is to create a world where most diseases are prevented, by giving people the power of molecular diagnostics. Siro also actively advises and co-founds start-ups through Roundcape, a boutique advisory firm, and is a Venture Partner at Hadean Ventures, a life sciences venture capital fund. Previously, he served as CEO of ToxiMet, leading the company from a development stage start-up to a fully commercial enterprise with sales in 5 continents, and raising £5m at increasing valuations in the process. Before joining ToxiMet, he worked investing in pharmaceutical and biotech stocks for one of the world’s leading hedge funds ($14B under management), and as Investment Manager for a global life sciences venture capital fund ($1.5B under management). Prior to his investment career, he worked as Project Leader in the Zurich office of The Boston Consulting Group, managing strategy projects for global Pharma, Biotech, and Financial Services companies. Prior to that, he led a group in drug development and conducted research in neurodegenerative diseases at Novartis, and started his scientific career at the Cajal Institute of Neurobiology, with several publications in peer-reviewed journals. Siro holds a Masters in Finance from the London Business School, and a PhD summa cum laude in Molecular Biology and a MSc in Chemistry with honours from the Autonoma University of Madrid. He also studied Computer Science Engineering at UNED, and speaks English, German, and Spanish fluently.

Co-Founder & CEO @ Creating a world where most diseases are prevented, by giving people the power of molecular diagnostics From April 2015 to Present (9 months) London, United KingdomVenture Partner @ Hadean Ventures' mission is to translate world class research to clinical utility and patient benefit. We do this by taking an active part in forming and funding new disruptive companies. Hadean Ventures takes its name from the first geologic eon, a turbulent period in which the Earth transformed from a gaseous cloud and emerged as a solid planet. From October 2014 to Present (1 year 3 months) Managing Director @ Our mission is to help entrepreneurs create the future. Roundcape helps entrepreneurs to create, fund, and grow their companies. We support you defining your vision, translating it into a winning strategy and business model, and securing funding to implement it. We are entrepreneurs ourselves, and have worked in the past for prestigious VCs, so we can help you understand how investors will assess your company, and work with you in the critical initial phases of your company, where every single decision will have profound impact on the future success of your company and your own personal wealth. Roundcape does not just provide advice, but instead works closely with you to actually make things happen. As entrepreneurs we know many people will happily give you opinions, but what you really need is someone to help you get things done. Visit our website to see how we can help you succeed, and read about the work we have done with other companies like yours. From May 2014 to Present (1 year 8 months) London, United KingdomChief Executive Officer @ ToxiMet is a start-up company with an innovative solution to measure toxins in food. Led the company from finalising product development, through the global launch in Singapore, and commercial expansion to five continents, achieving contract values of ~$850,000. Key achievements: - Raised ~£5m at increasing valuations from a range of investors, from business angels to family offices. Responsible for developing the investment presentations, pitching at multiple events, and supporting the due diligence processes to successful closing of the financings. - Restructured R&D operations and led the company to the successful global launch in time and in budget of our first product, a system for measurement of mycotoxins in food. Personally secured initial sales at the launch, allowing the company to fundraise for commercial expansion. - In charge of all marketing and sales strategy and materials, as well as setting up support systems (e.g. CRM). Marketing efforts led to the company being showcased in leading magazines, and receiving a key innovation award from our main customer group association. - Set up accounting processes and cost controls, and reduced average cash burn in the company by 50%, moving the company at the same time from a purely R&D organisation to a fully commercial enterprise. Led the recruitment of the commercial team. - Oversaw the constant quality improvement of the product, driving down manufacturing rejections and ensuring accurate and precise performance of the system. Drove manufacturing costs in consumables down by 70%, allowing the company to be much more competitive and grow revenues while improving profitability. - Established contact and secured partnerships with global companies to leverage their commercial resources and accelerate market penetration of our main product. - Initiated the search and supported the recruitment process for a CEO with extensive commercial experience to lead the company in the next growth stage From January 2012 to April 2014 (2 years 4 months) Analyst @ London, UK - Pharmaceuticals and Biotechnology Meeting with company management, research and financial modelling for global pharma and biotech investments. Buy/Sell recommendations and derivatives structuring From October 2011 to January 2012 (4 months) London, United KingdomInvestment Manager @ London, UK - Healthcare VC investing > Responsible for finding and assessing opportunities in life sciences/nutrition >> Sourced and assessed over 120 opportunities, negotiated and DD for three term sheets >> Strategy and business development for several portfolio companies From May 2010 to September 2011 (1 year 5 months) London, United KingdomProject Leader @ Zurich, Switzerland - Healthcare (Pharmaceuticals and Biotechnology) > Developed long term R&D strategy for international specialty Pharma > Defined efficiency and external innovation strategy for leading Pharma > Identified commercial operational improvements for international Biotech company > Conducted marketing excellence benchmarking at seven global Pharma/Biotech companies > Several other projects in Financial Services at leading international companies From January 2010 to April 2010 (4 months) Zürich Area, SwitzerlandConsultant @ Zurich, Switzerland. - Financial Services and Healthcare From October 2007 to December 2009 (2 years 3 months) Principal Scientist @ Basel, Switzerland. - Investigational Toxicology: Epigenetics & Gene Regulation. From October 2006 to September 2007 (1 year) Postdoctoral Researcher @ Basel, Switzerland. - Novartis Institutes for Biomedical Research: Neuroscience, Neurodegeneration. From January 2005 to September 2006 (1 year 9 months) Postdoctoral Researcher @ Madrid, Spain. Molecular Biology. From June 2004 to December 2004 (7 months) PhD Fellow @ Madrid, Spain. - Neurobiology, Molecular Biology. From August 1999 to May 2004 (4 years 10 months)

Masters in Finance, Investments, Achieved "concentration in Investments" @ London Business School From 2010 to 2012 Eng., Computer Science @ Universidad Nacional de Educación a Distancia - U.N.E.D. From 2002 to 2004 PhD, Biochemistry and Molecular Biology @ Universidad Autónoma de Madrid From 1999 to 2004 MSc, Biochemistry and Molecular Biology @ Universidad Autónoma de Madrid From 1994 to 1999 Siro Perez is skilled in: Lifesciences, Biotechnology, Pharmaceutical Industry, Molecular Biology, Strategy, R&D, Commercialization, Start-ups, Corporate Development, Business Planning, Drug Development, Private Equity, Business Development, Financial Modeling, Portfolio Management